news

Article courtasy of Purdue News Service. To see article in full, click below
http://www.purdue.edu/newsroom/general/2010/100830BOTFacilities.html

INDIANAPOLIS - The Purdue University Board of Trustees on Monday (Aug. 30) approved financing and constructing a drug discovery building.

The million drug discovery facility, to be located adjacent to the Hansen Life Science Research Building on the Life and Health Sciences Quadrangle, will, in part, replace aging existing lab space in Wetherill Laboratory and allow for the strict environmental control needed to successfully develop new drugs. Jeffrey Roberts, dean of the College of Science, said the new facility will bring some of Purdue's drug discovery researchers into a common facility that promotes and enables "cutting edge" work.

"Purdue has an amazingly successful group of faculty members who are pushing the frontiers of drug discovery," Roberts said. "The building will put Purdue on the map nationally as a center of excellence in drug discovery."

The facility will aid ongoing Purdue research that has already developed drug therapies to target cancer cells, including drugs that are being brought to market by Endocyte, a Purdue Research Park company.

Purdue will combine up to million in funds from gifts and facility and administrative cost recovery with million in bond proceeds to pay for the project, which is expected to be completed by July 2013.

Writer:  Jim Schenke, 765-494-6262, jschenke@purdue.edu

Article courtasy of Purdue News Service. To see article in full, click below
http://www.purdue.edu/newsroom/general/2010/100830BOTFacilities.html